LPS was used as a secondary stimulus because several TLR4 ligands have been detected in the synovial fluid of patients with active RA and also because low doses of LPS are commonly used to exemplify cross-tolerance in myeloid cells. The gene discussed is TLR4; the disease is rheumatoid arthritis.